Ical University, Guangzhou, People’s Republic of China) for Cyclopamine web technical advice
Ical University, Guangzhou, People’s Republic of China) for technical advice; Nan Jia (Nanfang Hospital) for technical assistance; and Huifeng Zhang (Southern Medical University, People’s Republic of China) for statistical analyses. This work was supported by Guangdong Science and Technology Plan Foundation Grant (2010B060900009) to Dr Li. Author details 1 Division of Nephrology, Huadu Hospital, Southern Medical University, Guangzhou, People’s Republic of China. 2Institute of Nephrology Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, People’s Republic of China. Received: 11 March 2013 Accepted: 10 January 2014 Published: 15 January 2014 References 1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813?18. 2. Schrier RW, Wang W, Poole B, Mitra A: Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004, 114:5?4. 3. Kellum JA, Decker JM: Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001, 29:1526?531. 4. Allgren PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/27321907 RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH: Anaritide in acute tubular necrosis: auriculin anaritide acute renal failure study group. N Engl J Med 1997, 336:828?34.10.11.12.13. 14.15. 16.17.18. 19.20.21.22.23.24.25.Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O’shea M, Baughman R, Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers B, Haenftling K, Capra W, et al: Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999, 55:2423?432. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, Foster CA, Zollinger M, Lynch KR: The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002, 277:21453?1457. Friedewald JJ, Rabb H: Inflammatory cells in ischemic acute renal failure. Kidney Int 2004, 66:486?91. Li H, Nord EP: CD40 ligation stimulates MCP-1 and IL-8 production, TRAF6 recruitment, and MAPK activation in proximal tubule cells. Am J Physiol Renal Physiol 2002, 282:F1020 1033. Gueler F, Rong S, Park JK, Fiebeler A, Menne J, Elger M, Mueller DN, Hampich F, Dechend R, Kunter U, Luft FC, Haller H: Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 2002, 13:2288?298. Sabbatini M, Pisani A, Uccello F, Serio V, Ser?R, Patern?R, Cianciaruso B, Fuiano G, Andreucci M: Atorvastatin improves the course of ischemic acute renal failure in aging rats. J Am Soc Nephrol 2004, 15:901?09. Yokota N, O’Donnell M, Daniels F, Burne-Taney M, Keane W, Kasiske B, Rabb H: Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol 2003, 23:13?7. Schouten O, Kok NF, Boersma E, Bax JJ, Feringa HH, Vidakovic R, van Eps RG S, van Sambeek MR, Poldermans D: Effects of statins on renal function after aortic cross clamping during major vascular surgery. Am J Cardiol 2006, 97:1383?385. D’Amico G: Statins and renal diseases: from primary prevention to renal replacement therapy. J Am Soc Nephrol 2006, 17:S148 152. Todorovic Z, Nesic Z, Stojanovi R, Basta-Jovanovi G,.
Posted inUncategorized